COTTESWOLD DAIRY LIMITED

Financial Health Score: A-

Explanation: Cotteswold Dairy Limited exhibits excellent financial health, akin to a robust and physically fit patient. The company has a strong "immune system" represented by growing net assets and stable cash reserves, and it has successfully reduced its total liabilities (lowered its "bad cholesterol"). The only slight concern is a minor dip in revenue (a mild arrhythmia in the top line), which prevents a perfect score but does not indicate any serious underlying illness given the strength of the balance sheet.

Key Vital Signs (Symptoms Analysis)

• Revenue Pulse (Turnover): £84.53 million (2023) vs £86.40 million (2022).
  • Analysis: The patient's pulse is strong but shows a slight slowdown, representing a 2.2% decrease in turnover year-on-year. In the dairy industry, which is heavily influenced by supermarket pricing and supply chain costs, this is a mild symptom of market pressure rather than a chronic condition.
• Net Assets (Bone Density): £8.51 million (2023) vs £7.20 million (2022).
  • Analysis: Excellent improvement. The company's structural foundation has strengthened by over 18%. This indicates that despite the slight drop in revenue, the business is retaining profits and building a very solid base to weather future economic shocks.
• Total Liabilities (Cholesterol Levels): £9.45 million (2023) vs £10.89 million (2022).
  • Analysis: The company has successfully reduced its total liabilities by over £1.4 million. This is the financial equivalent of lowering bad cholesterol—reducing the burden on the heart of the business and improving long-term cardiovascular health.
• Cash Reserves (Blood Pressure): £4.01 million (2023) vs £4.03 million (2022).
  • Analysis: Cash flow is the lifeblood of any business, and Cotteswold Dairy's blood pressure is remarkably stable. Maintaining over £4 million in cash while simultaneously reducing debt and growing net assets is a clear sign of a healthy, well-oxygenated financial circulatory system.
• Shareholders' Funds (Immune System): £8.51 million (2023) vs £7.20 million (2022).
  • Analysis: The equity buffer has grown, meaning the business has a stronger immune system to fight off unexpected financial infections or market downturns.

Diagnosis

The overall financial condition of Cotteswold Dairy Limited is very healthy. The business demonstrates the classic signs of prudent, long-term financial management—unsurprising for a company that has been operating since 1948.

The most encouraging symptom in this diagnosis is the simultaneous reduction in liabilities and growth in net assets, even while turnover experienced a slight contraction. This tells us that the "metabolism" of the business is highly efficient; management has successfully protected margins and converted trading activity into tangible wealth and debt reduction, rather than letting it leak out through uncontrolled expenses. The company is not over-leveraged, and its liquidity is strong. There are no visible symptoms of financial distress, insolvency risk, or cash flow asphyxiation.

Recommendations (Prescription for Continued Health)

1. Investigate the Revenue Dip (Preventative Screening): While the drop from £86.4m to £84.5m is not fatal, it requires a diagnostic investigation. Is this due to a loss of specific contracts, a strategic shift away from low-margin business, or broader macroeconomic pressures in the food sector? Identifying the root cause will prevent this minor symptom from becoming a chronic condition.
2. Strategic Reinvestment (Vaccination Against Stagnation): With cash reserves holding steady at £4 million and debt reducing, the company is in an excellent position to make strategic capital investments. Whether this is upgrading fleet and dairy equipment (capital expenditure), expanding depot coverage, or acquiring smaller competitors, deploying this cash effectively will ensure long-term growth.
3. Monitor Working Capital Cycle (Dietary Management): As a dairy producer, inventory and debtor management are crucial. Continue to enforce strict credit control and inventory turnover to ensure the cash conversion cycle remains swift, keeping the financial circulatory system flowing without blockages.